Press releases

2014-11-13 - 18:30

Genticel completes ProCervix phase II study enrollment ahead of schedule

2014-10-23 - 19:50

Business update - third quarter 2014

2014-09-30 - 18:10

Genticel to meet institutional investors during the Large and Midcap Event in Paris, October 2 and 3, 2014

2014-09-25 - 20:10

Business update and financial report June 30, 2014

2014-09-19 - 09:00

Mary Tanner appointed to Genticel's Supervisory Board as independently-acting member

2014-09-08 - 19:30

GENTICEL to participate in the Rodman and Renshaw investor conference in New York - from September 8 to 10

2014-07-24 - 20:00

Genticel granted five new patents in the US and Asia during first half of 2014

2014-07-16 - 20:25

Business Update - 2nd Quarter 2014

2014-07-10 - 21:30

Genticel's Phase II study with Procervix passes the halfway mark for patient recruitment

2014-06-23 - 16:30

Genticel meets US investors during "French Life Sciences Days" event in New York on June 25 et 26

2014-05-13 - 20:15

Activity - First Quarter 2014

2014-05-02 - 21:30

Genticel signs a liquidity contract with Oddo Corporate Finance

2014-05-02 - 20:05

Total size of the initial public offering and communication of the terms and conditions of the stabilization transactions

2014-04-03 - 20:30

Genticel lists on Euronext in Paris and Brussels

2014-03-19 - 08:15

Genticel launches its initial public offering on the regulated market Euronext in Paris and Brussels

2014-03-11 - 11:45

Genticel announces the registration of its "Document de base" in the context of the company's contemplated initial public offering on the Euronext Paris and Brussels regulated markets